Wockhardt Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Wockhardt Share Price

1,887.60-5.31 (-0.28%)

Closed
As On: 09 Jun, 2026, 04:00 PM IST
As On: 09 Jun, 2026, 03:57 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	1,907.00
High	1,978.00
Low	1,874.10
Prev Close	1,892.90
Volume	20,67,688
VWAP(₹)	1,909.49

Key Metrics

PE Ratio(x)	144.00
EPS - TTM(₹)	13.11
MCap(₹ Cr.)	30,672.02
MCap Rank	22
PB Ratio(x)	5.82
Div Yield(%)	-
Face Value(₹)	5.00
52W High(₹)	2,422.30
52W Low(₹)	1,086.70
MCap/Sales	5.65
Beta(1 Month)	1.27
BV/Share(₹)	325.00

Wockhardt share price insights

Rank 432 - ET 5002022 ranking

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 13.34% outperformed its 3 year CAGR of 7.82%. (Source: Consolidated Financials)
Candle Formations Yesterday
Black Spinning Top was formed for Wockhardt
Employee & Interest Expense
Company has spent 6.31% of its operating revenues towards interest expenses and 21.49% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Wockhardt Share Price Update
Wockhardt Ltd. share price moved down by -0.28% from its previous close of Rs 1,892.90. Wockhardt Ltd. stock last traded price is 1,887.60
Share Price Value
Today/Current/Last 1,887.601,887.05
Previous Day 1,892.901,893.65

Found Insights useful?

Wockhardt Share Price Returns

1 Day	-0.28%
1 Month	17.5%
3 Months	42.2%
1 Year	22.05%
3 Years	1001.6%
5 Years	184.53%

Wockhardt Share Recommendations

Recent Recos

Target₹280
OrganizationPrabhudas Lilladher
BUY

Target₹260
OrganizationSharekhan by BNP Paribas
BUY

Target₹400
OrganizationLKP Securities
BUY

View all Stock Recommendations

News & Analysis

View all Wockhardt Share News & Announcements

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	1,010.00	913.00	803.00	758.00	758.00
Total Income Growth (%)	10.62	13.70	5.94	0.00	3.98
Total Expenses	771.00	786.00	657.00	819.00	732.00
Total Expenses Growth (%)	-1.91	19.63	-19.78	11.89	12.96
EBIT	239.00	127.00	146.00	-61.00	26.00
EBIT Growth (%)	88.19	-13.01	-	-334.62	-67.90
Profit after Tax (PAT)	166.00	59.00	78.00	-90.00	-25.00
PAT Growth (%)	181.36	-24.36	-	-	-278.57
EBIT Margin (%)	23.66	13.91	18.18	-8.05	3.43
Net Profit Margin (%)	16.44	6.46	9.71	-11.87	-3.30
Basic EPS (₹)	10.23	3.61	4.81	-5.33	-1.57

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	571.00	457.00	410.00	438.00	369.00
Total Income Growth (%)	24.95	11.46	-6.39	18.70	11.48
Total Expenses	363.00	379.00	312.00	328.00	289.00
Total Expenses Growth (%)	-4.22	21.47	-4.88	13.49	-5.25
EBIT	208.00	78.00	98.00	110.00	80.00
EBIT Growth (%)	166.67	-20.41	-10.91	37.50	207.69
Profit after Tax (PAT)	167.00	28.00	54.00	69.00	40.00
PAT Growth (%)	496.43	-48.15	-21.74	72.50	-
EBIT Margin (%)	36.43	17.07	23.90	25.11	21.68
Net Profit Margin (%)	29.25	6.13	13.17	15.75	10.84
Basic EPS (₹)	10.29	1.73	3.26	4.25	2.47

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	3,484.00	3,074.00	2,881.00	2,773.00	3,250.00
Total Revenue Growth (%)	13.34	6.70	3.89	-14.68	14.41
Total Expenses	3,161.00	3,090.00	3,287.00	3,103.00	3,478.00
Total Expenses Growth (%)	2.30	-5.99	5.93	-10.78	6.48
Profit after Tax (PAT)	213.00	-47.00	-463.00	-559.00	-244.00
PAT Growth (%)	-	-	-	-	-135.57
Operating Profit Margin (%)	15.89	7.90	-3.60	-1.05	2.19
Net Profit Margin (%)	6.31	-1.56	-16.54	-21.08	-7.55
Basic EPS (₹)	13.12	-3.02	-32.05	-38.79	-20.24

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	1,876.00	1,457.00	1,195.00	1,139.00	1,410.00
Total Revenue Growth (%)	28.76	21.92	4.92	-19.22	37.16
Total Expenses	1,584.08	1,469.00	1,603.00	1,417.00	1,594.00
Total Expenses Growth (%)	7.83	-8.36	13.13	-11.10	5.61
Profit after Tax (PAT)	316.92	-12.00	-422.00	-466.00	-140.00
PAT Growth (%)	-	-	-	-	-123.60
Operating Profit Margin (%)	26.90	13.33	-14.81	-4.57	6.48
Net Profit Margin (%)	18.22	-0.85	-36.56	-43.47	-10.20
Basic EPS (₹)	19.54	-0.76	-29.27	-32.40	-11.62

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 13.34% outperformed its 3 year CAGR of 7.82%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 6.31% of its operating revenues towards interest expenses and 21.49% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	8,615.00	8,135.00	7,649.00	7,683.00	8,243.00
Total Assets Growth (%)	5.90	6.35	-0.44	-6.79	6.05
Total Liabilities	3,334.00	3,478.00	3,987.00	4,021.00	4,041.00
Total Liabilities Growth (%)	-4.14	-12.77	-0.85	-0.49	0.71
Total Equity	5,281.00	4,657.00	3,662.00	3,662.00	4,202.00
Total Equity Growth (%)	13.40	27.17	0.00	-12.85	11.75
Current Ratio (x)	1.66	1.26	0.78	0.64	0.81
Total Debt to Equity (x)	0.43	0.43	0.63	0.56	0.48
Contingent Liabilities	0.00	656.26	995.46	881.26	868.00

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	5,935.00	5,408.00	4,868.00	4,732.00	5,798.00
Total Assets Growth (%)	9.74	11.09	2.87	-18.39	18.45
Total Liabilities	2,851.00	2,645.00	3,072.00	2,979.00	3,586.00
Total Liabilities Growth (%)	7.79	-13.90	3.12	-16.93	9.03
Total Equity	3,084.00	2,763.00	1,796.00	1,753.00	2,212.00
Total Equity Growth (%)	11.62	53.84	2.45	-20.75	37.75
Current Ratio (x)	1.67	1.41	0.94	0.56	0.78
Total Debt to Equity (x)	0.57	0.55	1.00	0.92	0.72
Contingent Liabilities	0.00	583.46	935.46	898.26	25.00

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	390.00	-22.00	219.00	153.00	413.00
Net Cash used in Investing Activities	-241.00	-783.00	-137.00	-125.00	-201.00
Net Cash flow from Financing Activities	-54.00	409.00	334.00	-315.00	-71.00
Net Cash Flow	105.00	-393.00	415.00	-280.00	138.00
Closing Cash & Cash Equivalent	217.00	112.00	505.00	90.00	370.00
Closing Cash & Cash Equivalent Growth (%)	93.75	-77.82	461.11	-75.68	59.31
Total Debt/ CFO (x)	5.45	-84.50	9.64	12.33	4.51

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	241.00	-14.00	188.00	71.00	-93.00
Net Cash used in Investing Activities	-193.00	-900.00	-75.00	-3.00	-244.00
Net Cash flow from Financing Activities	-7.00	486.00	346.00	-236.00	430.00
Net Cash Flow	41.00	-428.00	459.00	-168.00	93.00
Closing Cash & Cash Equivalent	76.00	35.00	463.00	4.00	172.00
Closing Cash & Cash Equivalent Growth (%)	117.14	-92.44	0.00	-97.67	117.78
Total Debt/ CFO (x)	7.24	-109.07	9.52	22.82	-17.10

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 241.0 cr for investing activities which is an YoY decrease of 69.22%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	4.31	-1.07	-13.78	-16.66	-6.33
Return on Capital Employed (%)	7.66	3.90	-2.07	-0.65	1.40
Return on Assets (%)	2.47	-0.57	-6.05	-7.27	-2.96
Interest Coverage Ratio (x)	3.58	1.79	0.40	0.74	1.06
Asset Turnover Ratio (x)	0.40	0.38	0.36	0.33	0.20
Price to Earnings (x)	90.09	-500.00	-19.42	-3.97	-15.58
Price to Book (x)	3.86	5.30	2.68	0.66	0.99
EV/EBITDA (x)	27.90	55.03	89.12	19.23	17.63
EBITDA Margin (%)	22.62	15.10	4.36	8.41	9.84

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	10.27	-0.43	-23.49	-26.58	-6.32
Return on Capital Employed (%)	10.37	4.76	-5.73	-2.32	3.23
Return on Assets (%)	5.33	-0.22	-8.66	-9.84	-2.41
Interest Coverage Ratio (x)	3.72	1.78	0.02	0.60	0.95
Asset Turnover Ratio (x)	0.31	0.27	0.24	0.20	0.26
Price to Earnings (x)	60.24	-2,000.00	-21.32	-4.76	-27.17
Price to Book (x)	6.18	8.35	5.00	1.26	1.72
EV/EBITDA (x)	31.67	68.95	2,058.13	27.74	19.93
EBITDA Margin (%)	37.60	25.32	0.43	12.77	18.95

Found Financials useful?

Technicals

Buy/Sell Signals
5 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 5 Jun 2026
5D EMA: 1980.92
Last Signal 22 May 2026 (Loss -0.28%)
Average price decline of -3.36% within 7 days of Bearish signal in last 5 years
Price Analysis
43%
Positive Movement
since 1st Jan 2005
on basis
57%
Negative Movement
since 1st Jan 2005
on basis
Exclude
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 1952.37 Pivot
1913.23
S1 1848.47
R2 2017.13 S2 1809.33
R3 2121.03 S3 1705.43
Average True Range
5 Days 14 Days 28 Days
148.08 124.03 99.53

Found Technicals useful?

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Wockhardt	144.00	5.81	4.31	7.66	2.47	7.82	15.89	5.89	13.12	1.66	0.43	5.45
J B Chemicals	50.02	8.53	17.05	22.50	14.27	9.92	23.74	17.10	45.16	4.92	0.00	0.00
Emcure Pharmaceuticals Ltd.	35.78	6.65	18.67	25.65	9.61	15.02	15.88	10.22	48.77	1.46	0.24	1.28
Sai Life Science Ltd.	74.64	10.49	14.04	18.38	9.62	21.41	23.41	15.91	16.63	1.69	0.04	0.19
Piramal Pharma	-68.87	2.75	-3.99	2.29	-1.81	7.44	3.42	-4.31	-2.46	1.51	0.67	3.33
Add More

Annual Ratios (%)

Choose from Peers

Neuland Labs
OneSource Specialty
Eris Lifesciences
Syngene Int.
Jubilant Life

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Found Peer Comparison useful?

Shareholding Pattern

Total Shareholdings

Category	No. of Shares	Percentage	% Change QoQ
Promoters	7,97,58,848	49.08 %	0.00
Pledge	1,50,10,472	18.82 %	0.78
FII	1,15,16,860	7.09 %	0.08
DII	1,77,88,848	10.95 %	0.41
MF	1,31,89,581	8.12 %	0.35
Others	5,34,27,613	32.87 %	-0.50

QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 49.08 49.08 49.08 49.09
Pledge 18.82 18.04 21.30 15.64
FII 7.09 7.00 7.10 7.29
DII 10.95 10.54 10.99 11.00
Mutual Funds 8.12 7.76 7.89 8.02
Others 32.87 33.37 32.83 32.62

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Mirae Asset ELSS Tax Saver Direct-G
Equity: ELSS
3
- 299.85
  Amount Invested (in Cr.)
- 1.18674206%
  % of AUM
- 22.77
  % Change (MoM basis)
Tata Small Cap Direct-G
Equity: Small Cap
2
- 293.08
  Amount Invested (in Cr.)
- 2.59%
  % of AUM
- 0.00
  % Change (MoM basis)
HSBC Small Cap Direct-G
Equity: Small Cap
3
- 184.94
  Amount Invested (in Cr.)
- 1.13%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Wockhardt Top Searches

Corporate Actions

Recent
Board Meeting
Audited Results & Others
Apr 28, 2026
Board Meeting
Quarterly Results
Feb 04, 2026
General Meeting
-
Nov 17, 2025

Announced on	Meeting on
Apr 28, 2026	May 04, 2026
Audited Results & Others
Feb 04, 2026	Feb 10, 2026
Quarterly Results
Oct 29, 2025	Nov 03, 2025
Quarterly Results
Aug 01, 2025	Aug 08, 2025
Quarterly Results
May 26, 2025	May 29, 2025
Audited Results & Fund Raising

Dividends
Announced on Ex-Date Dividend%
Oct 28, 2016 Nov 17, 2016 200%
May 06, 2016 Aug 04, 2016 0%
Nov 03, 2014 Nov 13, 2014 400%
Feb 10, 2014 Feb 17, 2014 100%
Oct 25, 2013 Nov 07, 2013 100%
Bonus
Announced on Ex-Date
Feb 12, 2004 Apr 28, 2004
Bonus Ratio: 1 share(s) for every 2 shares held
Jan 24, 1995 -
Bonus Ratio: 1 share(s) for every 1 shares held
Splits
Announced on Ex-Date
Feb 12, 2004 Apr 28, 2004
Split: Old FV10.0| New FV:5.0
Rights
Announced on Ex-Date
Jan 06, 2022 Mar 08, 2022
Rights ratio: 3 share for every 10 held at a price of Rs 225.0
AGM/EGM Meetings
Announced on Meeting on
Nov 17, 2025 Dec 16, 2025
-
Jul 17, 2025 Aug 08, 2025
-
Jun 06, 2024 Jun 28, 2024
-
Jul 18, 2023 Aug 14, 2023
-
May 30, 2022 Aug 12, 2022
-

About Wockhardt

Wockhardt Ltd., incorporated in the year 1999, is a Small Cap company (having a market cap of Rs 30,672.02 Crore) operating in Pharmaceuticals sector.

Wockhardt Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Sale of services and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 1,010.00 Crore, up 10.62 % from last quarter Total Income of Rs 913.00 Crore and up 33.25 % from last year same quarter Total Income of Rs 758.00 Crore. Company has reported net profit after tax of Rs 164.00 Crore in latest quarter.

The company’s top management includes Dr.Habil Khorakiwala, Dr.Murtaza Khorakiwala, Dr.Huzaifa Khorakiwala, Ms.Zahabiya Khorakiwala, Mr.Ahmad Javed, Mr.Akhilesh Gupta, Ms.Amelia Fernandes, Mrs.Tasneem Mehta, Mr.Vinesh Kumar Jairath, Mr.Deepak Madnani, Ms.Rashmi Dinesh Mamtura. Company has MSKC & Associates LLP as its auditors. As on 31-03-2026, the company has a total of 16.25 Crore shares outstanding.

Wockhardt Share Price Today is Rs. 1887.60. On previous day, the Wockhardt Share Price (NSE) closed at Rs. 1892.9, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 49.08% of the stake in Wockhardt shares, out of which 18.82% was pledged. On the same date, foreign institutional investors' (FII) holdings of Wockhardt stocks was 7.09% as compared to 7.0% in Dec 2025 with increase of 0.09%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 10.95% as compared to 10.54% in Dec 2025 with increase of 0.41%. Out of the total DII holdings in Wockhardt shares 8.12% was held by mutual funds. The rest including public held is 32.88%. Wockhardt stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Wockhardt Dividend: Ever since 1999, Wockhardt dividends has been paid out around 20 times. As on 09 Jun, 2026, 04:00 PM IST, The overall dividend yield for Wockhardt stands at 0.0%. The last dividend paid was on November 17, 2016 (Rs. 10.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 13.11.

Wockhardt Bonus: The most recent bonus issue had been in year April 28, 2004 around 22 years ago at 2 : 1 ratio. The first bonus issue was announced in Jan 1995.

Stock Forecast:
After showing 1010.0 Cr. of sales and 10.62% of quarterly net profit, there have been multiple ups and downs in the Wockhardt stock prices in the past few weeks. For example, Wockhardt stock price on 2nd of June 2026 was around Rs. 1966.2. Wockhardt share price now stands at an average of Rs. 1887.60. Judging by last week's performance, stock is in down trend.

Wockhardt has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Wockhardt share.

Historical Prices and Performance:
Wockhardt, incorporated in 1999 is a Mid Cap company (with a market cap of Rs. 30672.02) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Wockhardt stock was 4.31%, -1.07%, -13.78%, -16.66% and -6.33% respectively.
The Wockhardt share gave a 3 year return of 1001.6% as compared to Nifty 50 which gave a return of 25.2%.
Wockhardt announced 200.0% final dividend on November 17, 2016.

Key Metrics:
PE Ratio of Wockhardt is 144.4
Prices/Sales Ratio of Wockhardt is 5.65
Price/Book Ratio of Wockhardt is 5.82

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Wockhardt, major competitors and peers include J B Chemicals, Emcure Pharmaceuticals Ltd., Sai Life Science Ltd. and Piramal Pharma. As of Dec 2025, the dividend yield of Wockhardt stands at 0.0% while J B Chemicals, Emcure Pharmaceuticals Ltd., Sai Life Science Ltd. and Piramal Pharma stand at 1.0%, 0.21%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 144.4 and 5.82 respectively.

Leadership of Wockhardt :
Rashmi Dinesh Mamtura is Co. Secretary & Compl. Officer
Deepak Madnani is Chief Financial Officer
Habil Khorakiwala is Founder Chairman
Murtaza Khorakiwala is Managing Director
Huzaifa Khorakiwala is Executive Director
Zahabiya Khorakiwala is Non Executive Director
Tasneem Mehta is Independent Director
Vinesh Kumar Jairath is Independent Director
Akhilesh Gupta is Independent Director
Amelia Fernandes is Independent Director
Ahmad Javed is Independent Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

Nifty Smallcap 100, Nifty 500, BSE 500, Nifty Pharma, Nifty Alpha 50

Address

D-4, MIDC,Chikalthana,Aurangabad, Maharashtra - 431006

Contact

investorrelations@wockhardt.com

http://www.wockhardt.com

Executive Leadership

HK

Habil Khorakiwala

Founder Chairman

MK

Murtaza Khorakiwala

Managing Director

HK

Huzaifa Khorakiwala

Executive Director

ZK

Zahabiya Khorakiwala

Non Executive Director

Show More

Auditors

MSKC & Associates LLP

B S R & Co. LLP

FAQs about Wockhardt share

1. What's the Wockhardt share price today?
Wockhardt share price is Rs 1,887.60 as on 09 Jun, 2026, 04:00 PM IST. Wockhardt share price is down by 0.28% based on previous share price of Rs. 1892.9.
2. What is Wockhardt's 52 week high / low?
Wockhardt share price saw a 52 week high of Rs 2,422.30 and 52 week low of Rs 1,086.70.
3. What is the PE & PB ratio of Wockhardt?
The PE ratio of Wockhardt stands at 144.0, while the PB ratio is 5.79.
4. What are the returns for Wockhardt share?
Return Performance of Wockhardt Shares:
- 1 Week: Wockhardt share price moved down by 8.98%
5. What's the market capitalization of Wockhardt?
Market Capitalization of Wockhardt stock is Rs 30,672.02 Cr.

Top Gainers

As on 03:43 PM | 09 Jun 2026

Data Patterns (India)

4,558.50

417.20 (10.08%)

3,417.70

252.50 (7.98%)

2,866.40

185.60 (6.93%)

2,255.20

144.20 (6.84%)

5,835.00

362.00 (6.62%)

Top Losers

As on 03:59 PM | 09 Jun 2026

Tata Technologies

745.10

-34.50 (-4.43%)

1,097.80

-45.11 (-3.95%)

107.62

-3.47 (-3.13%)

Krishna Instt of Medical Sciences

781.60

-19.61 (-2.45%)

Balrampur Chini

536.95

-13.45 (-2.45%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.